Kelli D. Plunket

A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport

William R. Oliver, Jennifer L. Shenk, Mike R. Snaith et al. · Proceedings of the National Academy of Sciences · 2001 · 1K citations · Full text

Molecular Pharmacology, Metabolic Syndrome, Insulin Signaling +15

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα

H. Eric Xu, Thomas B. Stanley, Valerie G. Montana et al. · Nature · 2002 · 608 citations

Transcriptional Regulation, Biochemistry, Molecular Regulation +5

Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662

Lisa M. Leesnitzer, Derek J. Parks, Randy K. Bledsoe et al. · Biochemistry · 2002 · 558 citations

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors

H. Eric Xu, Millard H. Lambert, Valerie G. Montana et al. · Proceedings of the National Academy of Sciences · 2001 · 529 citations · Full text

Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR

Patrick Maloney, Derek J. Parks, Curt D. Haffner et al. · Journal of Medicinal Chemistry · 2000 · 521 citations · Full text

Altmetric Attention Score, Molecular Biology, Research Triangle Park +19